Antifungal Activity of Nanocapsule Suspensions Containing Tea Tree Oil on the Growth of Trichophyton rubrum

Mycopathologia

Volumn 175, Issue 3-4, 2013, Pages 281-286

  Flores, F C ^a   de Lima, J A ^a   Ribeiro, R F ^a   Alves, S H ^a   Rolim, C M B ^a   Beck, R C R ^b   da Silva, Cristiane Bona ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Nanocapsules; Nanoemulsions; Onychomycosis; Tea tree oil; Trichophyton rubrum

Indexed keywords

MELALEUCA; MELALEUCA ALTERNIFOLIA; TRICHOPHYTON RUBRUM;

EID: 84876091223     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-013-9622-7     Document Type: Article

References (26)

1. Bakkali F, Averbeck S, Averbeck D, Idaormar M. Biological effects of essential oils-A review. Food Chem Toxicol. 2008; 46: 446-75.
2. Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 2000; 49: 619-26.
3. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006; 19(Suppl. 1): 50-62.
4. Hammer KA, Carson CF, Riley TV, Nielsen JB. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol. 2006; 44: 616-25.
5. Guterres SS, Alves MP, Pohlmann AR. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights. 2007; 2: 147-57.
6. Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine. 2010; 6: 9-24.
7. Noskin GA, Rubin RR, Schentag JJ, Kluytmans J, Hedblom EC, Smulders M, Lapentina E, Gemmen E. The burden of Staphylococcus aureus infections on hospitals in the United States. Arch Intern Med. 2005; 165(Suppl. 15): 1756-61.
8. Sidrim JJC, Rocha MFG. Micologia médica à luz de autores contemporâneos. Guanabara Koogan S. A., Copyright, Rio de Janeiro, RJ; 2004.
9. Degreef H. Clinical forms of dermatophytosis (Ringworm infection). Mycopathologia. 2008; 166: 257-65.
10. Nakashima T, Nozawa A, Ito T, Majima T. Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro. J. Infect Chemother. 2002; 8: 331-5.
11. Marty JPL. Amorolfine nail lacquer: a novel formulation. J Eur Acad Dermatol Venereol. 1995; 4(Suppl. 1): 17-21.
12. Baran R, Tosti A, Hartmane I, Altmeyer P, Hercogova J, Koudelkova V, Rozicka T, Combemale P, Mikazans I. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol. 2009; 23: 773-81.
13. Murdan S. Drug delivery to the nail following topical application. Int J Pharm. 2002; 236: 1-26.
14. Kobayashi Y, Komatsu T, Sumi M, Numajiri S, Miyamoto M, Kobayashi K, Morimoto Y. In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs. Eur J Pharm Sci. 2004; 21: 471-7.
15. Flores FC, Ribeiro RF, Ourique AF, Pohlmann AR, Beck RCR, Guterres SS, Rolim CMB, Silva CB. Nanostructured systems containing an essential oil: protection against volatilization. Quim Nova. 2011; 34: 968-72.
16. Bouchemal K, Briançon S, Perrier E, Fessi H. Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimization. Int J Pharm. 2004; 280: 241-51.
17. Fessi H, Puisieux F, Devissaguet JPh, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989; 55(Suppl. 1): R1-4.
18. Schaller M, Borelli C, Berger U, Walker B, Schimdt S, Weind G, Jäckels A. Susceptibility testing of apomorphine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. Med Mycol. 2009; 47: 753-8.
19. Yang D, Michel L, Chaumont JP, Millet-Clerc J. Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis. Mycopathologia. 1999; 148: 79-82.
20. Paulo CSO, Vidal M, Ferreira LS. Antifungal nanoparticles and surfaces. Biomacromolecules. 2010; 11: 2810-7.
21. Muralimohan A, Eun Y-J, Bhattacharyya B, Weibel DB. Dissecting microbiological systems using materials science. Trends Microbiol. 2009; 17(Suppl. 3): 100-8.
22. Lboutounne H, Chaulet JF, Ploton C, Falson F, Pirota P. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(e-caprolactone) nanocapsule encapsulated form and as a Digluconate. J. Control. Release. 2002; 82: 319-34.
23. Padmavathy N, Vijayaraghavan R. Enhanced bioactivity of ZnO Nanoparticles- an antimicrobial study. Sci Technol Adv Mater. 2008; 9: 35004-11.
24. Nhung DTT, Freydiere AM, Constant H, Falson F, Pirot F. Sustained antibacterial effect of a hand rub gel incorporating chlorhexidine-loaded nanocapsules (Nanochlorex®). Int J Pharm. 2007; 334: 166-72.
25. Ranjita S, Loaye AS, Khalil M. Present status of nanoparticle research for treatment of tuberculosis. J. Pharm. Pharm. Sci. 2011; 4(Suppl. 1): 100-16.
26. Gunt H, Kasting GB. Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eur J Pharm Sci. 2007; 32: 254-60.